ClinicalTrials.Veeva

Menu

Quantifying Patellar Tendon Microstructure Using DTI

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Completed

Conditions

Anterior Cruciate Ligament Reconstruction
Patellar Tendinopathy

Treatments

Device: Neuromuscular electric stimulation (NMES)
Device: Ultrasound (US)
Device: MRI

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT06381492
Protocol Version 10/1/2025 (Other Identifier)
1K99AR085752-01 (U.S. NIH Grant/Contract)
2024-0057
A536130 (Other Identifier)
SMPH/ORTHO&REHAB/PHYS THER (Other Identifier)

Details and patient eligibility

About

The goal of this observational study is to understand how diffusion tensor imaging (DTI) relates to other traditional measures and knee function. The main question it aims to answer is:

Will regions of known patellar tendon pathology present with smaller DTI scalar parameters, shorter fiber length, and lower fiber density compared to the contralateral tendon and healthy regions in the ipsilateral tendon.

Participants will:

  • undergo MRI and ultrasound imaging
  • perform knee function test
  • complete questionnaires

Full description

Patellar tendon injuries are commonly accompanied by macrostructural alterations captured on common imaging modalities, and the extent of these alterations correlate to knee joint function. Evidence for using tendon macrostructure for diagnosis and prognosis of tendon injuries is not as clear, suggesting that these imaging modalities are not providing a complete picture of the alterations. Diffusion tensor imaging (DTI) tractography can quantify tendon microstructures that underlie the alterations in pathological tendons and shows promising results in healthy tendons. This study is the first step in evaluating whether tendon microstructure captured using DTI technology can be applied as a biomarker to optimize treatment for patellar tendon injuries.

Enrollment

62 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Have patellar tendon injury as confirmed through subjective report, clinical examination, and ultrasound by an experienced physical therapist
  • Patellar tendinopathy group must present with current symptoms of patellar tendinopathy
  • Control group must have no history of patellar tendon injury

Exclusion criteria

  • Participants with a history of invasive procedures other than bone-patellar tendon-bone (BPTB) autograft harvest to the patellar tendon or extensor mechanism
  • Participants with history of contralateral BPTB autograft harvest, or ACLR using any other graft type
  • Participants with contraindications to MRI
  • Participants with contraindications to NMES

Trial design

62 participants in 3 patient groups

Bone-patellar tendon-bone (BPTB)
Description:
This group will have patellar injury confirmed through self-reported surgical history and evidence of ipsilateral BPTB graft harvest on ultrasound.
Treatment:
Device: MRI
Device: Neuromuscular electric stimulation (NMES)
Device: Ultrasound (US)
Patellar tendinopathy group
Description:
This group will have patellar tendinopathy confirmed based on International Scientific Tendinopathy Symposium Consensus on Clinical Terminology (ICON) statement, which defines patellar tendinopathy as "persistent patellar tendon pain and loss of function related to mechanical loading." Ultrasound diagnosis must confirm alteration of tendon macrostructure.
Treatment:
Device: MRI
Device: Neuromuscular electric stimulation (NMES)
Device: Ultrasound (US)
Healthy knees
Description:
Control group of participants with healthy knees
Treatment:
Device: MRI
Device: Neuromuscular electric stimulation (NMES)
Device: Ultrasound (US)

Trial contacts and locations

1

Loading...

Central trial contact

Naoaki Ito

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems